Hifer 100mg5ml Injection 5s

What it is used for: Fluids & Electrolytes.

Indications as listed by the manufacturer: Iron sucrose is indicated for the treatment of iron deficiency in the following: - Where there is a clinical need to deliver iron rapidly to iron stores. - Patients who cannot tolerate oral iron therapy or who are noncompliant. - In active inflammatory bowel disease where oral iron preparations are ineffective. - Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients receiving an erythropoietin. - Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients not receiving an erythropoietin. - Hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin. - Peritoneal dialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin

How it works: Iron sucrose injection is in a class of medications called iron replacement products. It works by replenishing iron stores so that the body can make more red blood cells.

Active ingredient: Iron sucrose.

Reported side effects: Common: transient taste perversions (in particular metallic taste). Uncommon: headache, dizziness, hypotension and collapse, tachycardia, palpitations, bronchospasm, dyspnea, nausea, vomiting, abdominal pain, diarrhea pruritus, urticaria, rash, exanthema, erythema, muscle cramps, myalgia, fever, shivering, flushing, chest pain and tightness. Injection site disorders such as superficial phlebitis, burning, swelling. Rare: paresthesia, anaphylactoid reactions (rarely involving arthralgia), peripheral edema, fatigue, asthenia, malaise. Isolated cases: reduced level of consciousness, light-headed feeling, confusion, angioedema, swelling of joints, hyperhidrosis and back pain. Hemodialyis dependent-chronic kidney disease (HDD-CKD) patients: hypotension, muscle cramps, nausea, headache, graft complications, vomiting, dizziness, hypertension, chest pain and diarrhea. Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients: dysgeusia, peripheral edema, diarrhea, constipation, nausea, dizziness and hypertension . Patients receiving erythropoietin may experience: diarrhea, edema, nausea, vomiting, arthralgia, back pain, headache, hypertension, dysgeusia, dizziness, extremity pain and injection site burning. Peritoneal dialysis dependent-chronic kidney disease (PDD-CKD) patients: diarrhea, peritoneal infection, vomiting, hypertension, pharyngitis, peripheral edema and nausea.

Known drug interactions: As with all parenteral iron preparations, iron sucrose should not be administered concomitantly with oral iron preparations since the absorption of oral iron is reduced. Therefore, oral iron therapy should be started at least 5 days after the last injection of Iron Sucrose.

The usual dosage is 5-10ml Iron sucrose (100-200mg iron) one to three times a week depending on the hemoglobin level. Children : If there is a clinical need, it is recommended not to exceed 0.15ml Iron sucrose (3mg iron) per kg one to three times per week depending on the hemoglobin level. Maximum Dose: Intravenous Infusion The maximum tolerated single dose is 7mg iron per kg body weight given once per week, but not exceeding 500mg iron. Intravenous Injection The maximum allowed single dose is 200mg iron. If the total necessary dose exceeds the maximum allowed single dose, then the administration has to be split. OR As directed by your physician.

Follow your doctor’s instructions. The dosage above is the usual range — your prescription takes precedence over it.

Active ingredient: Iron sucrose. Labelled strength: 100mg/5ml.

Store this medicine at room temperature, away from direct light and heat.

Manufactured by Hifer Laboratories (Pvt) Ltd.. Country of origin: Pakistan.